Furthermore, the prognostic potential of two key biomarkers, namely, plasma glial fibrillary acidic protein (pGFAP) and plasma neurofilament light chain (pNfL), has garnered attention within the context of FTD. The gene discussed is NEFL; the disease is frontotemporal dementia.